Repligen | Ativo Circulante

Preço das Ações
136.44
Mudança Diária
3.81 2.87%
Mensal
-15.79%
Anual
-7.13%
Q1 Previsão
132.21




Ativo Circulante Alterar Data
Agilent USD 4.59B 341M 2025-09
Align Technology USD 2.62B 82.47M 2025-12
Bio Techne USD 637.43M 27.92M 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Bruker USD 2.21B 138.1M 2025-12
Charles River Laboratories USD 1.53B 62.24M 2025-09
Danaher USD 12.76B 3.15B 2025-12
Dentsply International USD 2.07B 106M 2025-09
Exact Sciences USD 1.56B 34.88M 2025-12
General Electric Aerospace USD 40.6B 522M 2025-12
Henry Schein USD 4.4B 152M 2025-09
Illumina USD 3.29B 493M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
Mettler Toledo International USD 1.36B 81.46M 2025-12
Myriad Genetics USD 344.8M 60.5M 2025-09
OraSure Technologies USD 283.01M 18.43M 2025-09
Pacific Biosciences Of California USD 394.24M 19.16M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Repligen USD 1.1B 39.62M 2025-09
Revvity USD 2.24B 95.96M 2025-12
Standard Biotools USD 472.44M 33.6M 2025-09
Thermo Fisher Scientific USD 28.71B 6.41B 2025-12
Waters USD 1.99B 69.86M 2025-12
West Pharmaceutical Services USD 1.98B 154.9M 2025-12


Repligen Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.